Literature DB >> 25853400

Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.

G Cennamo1, R S Auriemma2, D Cardone1, L F S Grasso3, N Velotti1, C Simeoli3, C Di Somma3, R Pivonello3, A Colao3, G de Crecchio1.   

Abstract

PURPOSE: The aim of this prospective study was to measure the thickness of the circumpapillary retinal nerve fibre layer (cpRNFL) and the ganglion cell complex (GCC) using spectral domain optical coherence tomography (SD-OCT) in a cohort of consecutive de novo patients with pituitary macroadenomas without chiasmal compression. PATIENTS AND METHODS: Twenty-two consecutive patients with pituitary macroadenoma without chiasmal compression (16 men, 6 women, aged 45.2±14.6 years, 43 eyes) entered the study between September 2011 and June 2013. Among them, 31.8% harboured a growth hormone-secreting pituitary adenoma, 27.3% a prolactin-secreting pituitary adenoma, 27.3% a corticotrophin-secreting pituitary adenoma, and 13.6% a non-secreting pituitary tumour. Eighteen subjects (nine females, nine males, mean age 36.47±6.37 years; 33 eyes) without pituitary adenoma, with normal ophthalmic examination, served as controls. In both patients and controls, cpRNFL and GCC thicknesses were measured by SD-OCT.
RESULTS: Patients were significantly older (P=0.02) than controls. Best corrected visual acuity, intraocular pressure, colour fundus photography, and automatic perimetry test were within the normal range in patients and controls. Conversely, cpRNFL (P=0.009) and GCC (P<0.0001) were significantly thinner in patients than in controls. The average GCC (r=0.306, P=0.046) significantly correlated with the presence of arterial hypertension. OCT parameters did not differ significantly between patients with a tumour volume above the median and those with a tumour volume below the median.
CONCLUSION: Pituitary macroadenomas, even in the absence of chiasmal compression, may induce GCC and retinal nerve fibre layer thinning. SD-OCT may have a role in the early diagnosis and management of patients with pituitary tumours.

Entities:  

Mesh:

Year:  2015        PMID: 25853400      PMCID: PMC4469667          DOI: 10.1038/eye.2015.35

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  23 in total

Review 1.  Imaging of the pituitary and parasellar region.

Authors:  Chi S Zee; John L Go; Paul E Kim; David Mitchell; Jamshid Ahmadi
Journal:  Neurosurg Clin N Am       Date:  2003-01       Impact factor: 2.509

2.  Optical coherence tomography analysis of axonal loss in band atrophy of the optic nerve.

Authors:  M L R Monteiro; B C Leal; A A M Rosa; M D Bronstein
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment.

Authors:  Rosario Pivonello; Carmela Matrone; Mariagiovanna Filippella; Luigi M Cavallo; Carolina Di Somma; Paolo Cappabianca; Annamaria Colao; Lucio Annunziato; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

4.  Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors.

Authors:  Lori M Ventura; Frank X Venzara; Vittorio Porciatti
Journal:  Doc Ophthalmol       Date:  2008-08-01       Impact factor: 2.379

5.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage.

Authors:  A Colao; A Di Sarno; M L Landi; S Cirillo; F Sarnacchiaro; G Facciolli; R Pivonello; M Cataldi; B Merola; L Annunziato; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.

Authors:  Elise M Pelletier; Boyung Shim; Rami Ben-Joseph; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  The role of optical coherence tomography in the detection of pituitary adenoma.

Authors:  Charlotta Johansson; Bertil Lindblom
Journal:  Acta Ophthalmol       Date:  2008-09-03       Impact factor: 3.761

10.  Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography.

Authors:  Maud Jacob; Gérald Raverot; Emmanuel Jouanneau; Françoise Borson-Chazot; Gilles Perrin; Muriel Rabilloud; Caroline Tilikete; Martine Bernard; Alain Vighetto
Journal:  Am J Ophthalmol       Date:  2008-09-06       Impact factor: 5.258

View more
  10 in total

1.  Retina ganglion cell/inner plexiform layer and peripapillary nerve fiber layer thickness in patients with acromegaly.

Authors:  Muhammed Şahin; Alparslan Şahin; Faruk Kılınç; Harun Yüksel; Zeynep Gürsel Özkurt; Fatih Mehmet Türkcü; Zafer Pekkolay; Hikmet Soylu; İhsan Çaça
Journal:  Int Ophthalmol       Date:  2016-08-04       Impact factor: 2.031

2.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

Review 3.  Optical coherence tomography impacts the evaluation of visual pathway tumors.

Authors:  Ana Banc; Cristina Stan; Ioan Stefan Florian
Journal:  Neurosurg Rev       Date:  2016-07-28       Impact factor: 3.042

4.  The Effect of Timing of Surgery in Pituitary Apoplexy on Continuously Valued Visual Acuity.

Authors:  Patrick D Kelly; Shanik J Fernando; Jordan A Malenke; Rakesh K Chandra; Justin H Turner; Lola B Chambless
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-24

5.  Interocular Symmetry of Macular Ganglion Cell Complex Thickness in Young Chinese Subjects.

Authors:  Minwen Zhou; Bing Lu; Jingke Zhao; Qiu Wang; Pengfei Zhang; Xiaodong Sun
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

6.  Optical coherence tomography and visual evoked potentials in evaluation of optic chiasm decompression.

Authors:  Pavel Poczos; Tomáš Česák; Naďa Jirásková; Markéta Macháčková; Petr Čelakovský; Jaroslav Adamkov; Filip Gabalec; Jiří Soukup; Jan Kremláček
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.996

7.  Predictive value of retinal nerve fibre layer thickness for postoperative visual improvement in patients with pituitary macroadenoma.

Authors:  Deepthi Elizabeth Kurian; Rajshekhar V; Saban Horo; Ari G Chacko; Krishna Prabhu; Gowri Mahasampath; Sanita Korah
Journal:  BMJ Open Ophthalmol       Date:  2022-07

8.  Analysis of Retinal Layer Thicknesses and Their Clinical Correlation in Patients with Traumatic Optic Neuropathy.

Authors:  Ju-Yeun Lee; Kyuyeon Cho; Kyung-Ah Park; Sei Yeul Oh
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

Review 9.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

10.  Evaluation of Peripapillary Microcirculation in Patients with Acromegaly.

Authors:  Mine Karahan; Atilim Armagan Demirtas; Leyla Hazar; Sedat Ava; Zafer Pekkolay; Ugur Keklikci
Journal:  Beyoglu Eye J       Date:  2021-12-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.